Understanding the immunological interactions of engineered nanomaterials: Role of the bio-corona.

bio-corona danger immune system molecular patterns nanomaterials

Journal

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
ISSN: 1939-0041
Titre abrégé: Wiley Interdiscip Rev Nanomed Nanobiotechnol
Pays: United States
ID NLM: 101508311

Informations de publication

Date de publication:
11 2022
Historique:
revised: 09 03 2022
received: 10 02 2022
accepted: 15 03 2022
entrez: 23 11 2022
pubmed: 24 11 2022
medline: 25 11 2022
Statut: ppublish

Résumé

Engineered nanomaterials are a broad class of materials with the potential for breakthrough applications in many sectors of society not least in medicine. Consequently, safety assessment of nanomaterials and nano-enabled products with respect to human health and the environment is of key importance. To this end, the biological interactions of nanoscale materials must be understood. Here, the dual "identities" of nanomaterials, namely, the material-intrinsic properties or synthetic identity and the acquired, context-dependent properties or biological identity, are discussed in relation to nanomaterial interactions with the immune system, our main defense against foreign intrusion. Specifically, we address whether macrophages and other innate immune cells respond to the synthetic identity or the biological identity of nanomaterials, that is, the surface adsorbed proteins and/or other biomolecules known as the bio-corona, or both? This article is categorized under: Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials.

Identifiants

pubmed: 36416023
doi: 10.1002/wnan.1798
pmc: PMC9787869
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1798

Informations de copyright

© 2022 The Author. WIREs Nanomedicine and Nanobiotechnology published by Wiley Periodicals LLC.

Références

Nat Rev Immunol. 2013 Sep;13(9):621-34
pubmed: 23928573
Small. 2017 Nov;13(41):
pubmed: 28922574
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Nature. 2022 Jan;601(7893):366-373
pubmed: 35046606
Trends Immunol. 2002 Mar;23(3):130-5
pubmed: 11864840
ACS Nano. 2013 May 28;7(5):4289-98
pubmed: 23614696
Nat Nanotechnol. 2021 Jun;16(6):617-629
pubmed: 34117462
Angew Chem Int Ed Engl. 2014 Nov 10;53(46):12304-19
pubmed: 25302857
Nanoscale. 2010 Dec;2(12):2514-20
pubmed: 20877789
Nat Nanotechnol. 2013 Oct;8(10):772-81
pubmed: 24056901
Small. 2020 Sep;16(36):e2002228
pubmed: 32743899
Nature. 2021 Apr;592(7854):457-462
pubmed: 33731934
Nat Commun. 2021 Jan 28;12(1):648
pubmed: 33510170
ACS Nano. 2013 Dec 23;7(12):10960-70
pubmed: 24256422
Cell. 2008 May 2;133(3):415-26
pubmed: 18455983
ACS Nano. 2016 Nov 22;10(11):10471-10479
pubmed: 27797479
Occup Environ Med. 2004 Sep;61(9):727-8
pubmed: 15317911
Nat Rev Immunol. 2020 Feb;20(2):95-112
pubmed: 31558839
Science. 2015 Oct 23;350(6259):388-9
pubmed: 26494749
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14265-70
pubmed: 18809927
Biomacromolecules. 2017 Feb 13;18(2):431-439
pubmed: 28075126
Nat Nanotechnol. 2022 Jan;17(1):86-97
pubmed: 34795440
JAMA. 2015 Jan 13;313(2):135-6
pubmed: 25585320
J Am Chem Soc. 2012 Mar 7;134(9):3965-7
pubmed: 22339432
Annu Rev Immunol. 1994;12:991-1045
pubmed: 8011301
Biomaterials. 2017 Mar;121:28-40
pubmed: 28063981
Cell. 2010 Mar 19;140(6):805-20
pubmed: 20303872
Front Plant Sci. 2014 Oct 31;5:578
pubmed: 25400647
Biomaterials. 2015 May;51:58-68
pubmed: 25770998
Arch Toxicol. 2017 Mar;91(3):1031-1048
pubmed: 27438349
Nature. 2003 Oct 2;425(6957):516-21
pubmed: 14520412
Nat Nanotechnol. 2016 Apr;11(4):372-7
pubmed: 26878141
Nano Lett. 2021 Jun 9;21(11):4530-4538
pubmed: 34042452
Nat Nanotechnol. 2007 Aug;2(8):469-78
pubmed: 18654343
Adv Sci (Weinh). 2020 Jun 18;7(15):2000912
pubmed: 32775166
Nature. 2009 Apr 30;458(7242):1191-5
pubmed: 19252480
Acc Chem Res. 2013 Mar 19;46(3):681-91
pubmed: 23294365
ACS Nano. 2015 Aug 25;9(8):8142-56
pubmed: 26135229
J Exp Med. 1999 May 3;189(9):1497-506
pubmed: 10224290
Cell Death Dis. 2019 Jul 29;10(8):569
pubmed: 31358731
Immunol Cell Biol. 2016 Feb;94(2):164-8
pubmed: 26215791
Nano Lett. 2006 Aug;6(8):1682-6
pubmed: 16895356
Blood. 2014 Jul 31;124(5):710-9
pubmed: 24923297
Nature. 2016 Jul 06;535(7610):75-84
pubmed: 27383982
Toxicol Sci. 2015 Jan;143(1):136-46
pubmed: 25326241
ACS Appl Mater Interfaces. 2021 Sep 29;13(38):45300-45314
pubmed: 34543013
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Nov;14(6):e1798
pubmed: 36416023
Nat Biotechnol. 2010 Dec;28(12):1275-6
pubmed: 21139613
Immunity. 2013 Jun 27;38(6):1142-53
pubmed: 23809161
Toxicol Sci. 2021 Dec 28;185(1):105-116
pubmed: 34633463
Nature. 2020 Jul;583(7815):296-302
pubmed: 32612232
Sci Rep. 2019 Mar 13;9(1):4366
pubmed: 30867451
Regul Toxicol Pharmacol. 2015 Mar 15;71(2 Suppl):S1-27
pubmed: 25818068
Adv Sci (Weinh). 2021 Mar 01;8(8):2004979
pubmed: 33898204
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Mar-Apr;5(2):111-29
pubmed: 23335558
Science. 2002 Apr 12;296(5566):301-5
pubmed: 11951032
Nanoscale. 2017 Jun 29;9(25):8858-8870
pubmed: 28632260
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jul;12(4):e1615
pubmed: 32003104
ACS Appl Mater Interfaces. 2020 Jan 15;12(2):1997-2008
pubmed: 31867945
Nat Nanotechnol. 2011 Jan;6(1):39-44
pubmed: 21170037
ACS Nano. 2012 Mar 27;6(3):1925-38
pubmed: 22303956
ACS Nano. 2009 Sep 22;3(9):2461-8
pubmed: 19728690
Nature. 2016 Jul 06;535(7610):65-74
pubmed: 27383981
Eur J Pharm Biopharm. 2015 Sep;95(Pt A):3-12
pubmed: 25770769
ACS Nano. 2012 Jul 24;6(7):5845-57
pubmed: 22721453
Immunol Today. 1992 Jan;13(1):11-6
pubmed: 1739426
ACS Nano. 2011 Jun 28;5(6):4300-9
pubmed: 21528863
Biomaterials. 2009 Aug;30(23-24):3926-33
pubmed: 19394687
Curr Opin Biotechnol. 2013 Aug;24(4):724-34
pubmed: 23768801
J Immunol. 2004 Jan 15;172(2):1125-31
pubmed: 14707087
Nat Commun. 2020 Jun 16;11(1):3048
pubmed: 32546688
Cell Rep. 2017 Jan 31;18(5):1298-1311
pubmed: 28147282
Trends Immunol. 2007 Oct;28(10):429-36
pubmed: 17845865
J Immunol. 2008 Nov 1;181(9):6574-83
pubmed: 18941248
Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):E4110-8
pubmed: 25225402
Adv Mater. 2019 Jan;31(4):e1803335
pubmed: 30488990
ACS Nano. 2011 May 24;5(5):3693-700
pubmed: 21500856
Nat Commun. 2021 Sep 2;12(1):5246
pubmed: 34475383
Lancet. 2005 Mar 12-18;365(9463):923-4
pubmed: 15766981
Nanoscale. 2020 Aug 7;12(29):15857-15868
pubmed: 32696774
Nat Nanotechnol. 2018 Jul;13(7):537-543
pubmed: 29980781
ACS Nano. 2014 Jun 24;8(6):5515-26
pubmed: 24797313
Immunity. 2014 Dec 18;41(6):886-97
pubmed: 25526304
Nat Nanotechnol. 2012 Dec;7(12):779-86
pubmed: 23212421
J Immunol. 2005 Nov 1;175(9):6058-64
pubmed: 16237101
Annu Rev Pharmacol Toxicol. 2010;50:63-88
pubmed: 20055698
Adv Exp Med Biol. 2017;947:143-171
pubmed: 28168668
ACS Nano. 2017 Mar 28;11(3):2428-2443
pubmed: 28040885
Regul Toxicol Pharmacol. 2016 Apr;76:234-61
pubmed: 26687418
Nat Nanotechnol. 2021 Aug;16(8):926-932
pubmed: 33986512
Sci Rep. 2018 Jan 18;8(1):1115
pubmed: 29348435
ACS Nano. 2017 May 23;11(5):4606-4616
pubmed: 28460159
Cell Rep. 2021 Feb 9;34(6):108734
pubmed: 33567275
Nature. 2020 Jul;583(7815):206-207
pubmed: 32623443
FEBS J. 2009 Jun;276(12):3372-81
pubmed: 19438706
Nanoscale. 2015 Oct 7;7(37):15268-76
pubmed: 26324751
Cell Host Microbe. 2011 May 19;9(5):355-61
pubmed: 21575907
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17224-9
pubmed: 25413365
Nat Nanotechnol. 2020 Mar;15(3):164
pubmed: 32123379
ACS Nano. 2014 Apr 22;8(4):3357-66
pubmed: 24617595
ACS Nano. 2014 Mar 25;8(3):2439-55
pubmed: 24517450
Science. 2002 Apr 12;296(5566):298-300
pubmed: 11951031
J Proteome Res. 2017 Feb 3;16(2):689-697
pubmed: 27973853
Front Immunol. 2021 Apr 29;12:662164
pubmed: 33995387
Science. 2015 May 22;348(6237):aaa6566
pubmed: 25999512
Nat Commun. 2019 Aug 15;10(1):3686
pubmed: 31417080
Acc Chem Res. 2013 Mar 19;46(3):622-31
pubmed: 22891796
ACS Nano. 2011 Sep 27;5(9):7503-9
pubmed: 21861491
ACS Nano. 2011 Mar 22;5(3):1657-69
pubmed: 21344890
Crit Rev Biochem Mol Biol. 2009 Sep-Oct;44(5):264-77
pubmed: 19780638
Nat Nanotechnol. 2021 Mar;16(3):266-276
pubmed: 33712737
Nat Rev Immunol. 2020 May;20(5):308-320
pubmed: 32015472
Nat Nanotechnol. 2021 Nov;16(11):1180-1194
pubmed: 34759355
Environ Health Perspect. 2005 Jul;113(7):823-39
pubmed: 16002369
Nat Nanotechnol. 2019 Dec;14(12):1084-1087
pubmed: 31802031
Nat Nanotechnol. 2009 Jul;4(7):396-7
pubmed: 19581881
Nano Lett. 2021 Oct 13;21(19):8250-8257
pubmed: 34554750
Nat Rev Immunol. 2008 Apr;8(4):279-89
pubmed: 18340345
Nat Commun. 2017 Oct 3;8(1):777
pubmed: 28974673
ACS Nano. 2011 Sep 27;5(9):7155-67
pubmed: 21866933
Nano Today. 2019 Oct;28:
pubmed: 32774443
Nat Nanotechnol. 2019 Nov;14(11):996-998
pubmed: 31695147
Front Immunol. 2012 Sep 17;3:287
pubmed: 23060876
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):E345
pubmed: 25540422
ACS Nano. 2020 Nov 24;14(11):15723-15737
pubmed: 33112593
Curr Opin Toxicol. 2018 Aug;10:8-14
pubmed: 29577105
J Control Release. 2012 Jul 20;161(2):403-8
pubmed: 22306428
Part Fibre Toxicol. 2021 Oct 30;18(1):40
pubmed: 34717665
ACS Nano. 2019 Oct 22;13(10):11107-11121
pubmed: 31525954
Adv Mater. 2020 Jan;32(1):e1903878
pubmed: 31686433
Nanoscale. 2014 Apr 7;6(7):3488-95
pubmed: 24548972
Nature. 2002 Jul 11;418(6894):191-5
pubmed: 12110890
Adv Sci (Weinh). 2020 Oct 11;7(22):2002221
pubmed: 33240770
Nanoscale. 2016 Mar 14;8(10):5526-36
pubmed: 26804616
Nat Nanotechnol. 2018 Sep;13(9):777-785
pubmed: 30190620
Science. 2020 Sep 25;369(6511):
pubmed: 32973003
Trends Immunol. 2002 Jul;23(7):342-3
pubmed: 12103350
Small. 2020 Nov;16(46):e2000892
pubmed: 33107223
Biomaterials. 2021 Jan;265:120452
pubmed: 33190736
Nat Rev Immunol. 2004 Jun;4(6):469-78
pubmed: 15173835
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20388-93
pubmed: 19918053
Nat Rev Immunol. 2022 May;22(5):322-330
pubmed: 34548649
Nat Rev Immunol. 2016 Jul;16(7):407-20
pubmed: 27291964
Immunity. 2009 Jun 19;30(6):766-75
pubmed: 19538928
Nat Rev Immunol. 2017 Mar;17(3):208-214
pubmed: 28163301
Swiss Med Wkly. 2012 Jun 26;142:w13609
pubmed: 22736064
Theranostics. 2020 Jan 1;10(3):1213-1229
pubmed: 31938061
Nat Nanotechnol. 2019 Jul;14(7):629-635
pubmed: 31270452
Nat Mater. 2009 Jul;8(7):543-57
pubmed: 19525947
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2050-5
pubmed: 17267609
Nat Commun. 2018 Jun 19;9(1):2393
pubmed: 29921862
Nanoscale. 2015 Nov 14;7(42):17710-28
pubmed: 26451907
Nanotoxicology. 2016 Dec;10(10):1555-1564
pubmed: 27705051
Nat Biotechnol. 2003 Oct;21(10):1161-5
pubmed: 14520400

Auteurs

Bengt Fadeel (B)

Nanosafety & Nanomedicine Laboratory (NNL), Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH